
Thyroid Function Test Market Report 2026
Global Outlook – By Test Type (Thyroid Stimulating Hormone (TSH), Triiodothyronine (T3), Thyroxine (T4), Free Triiodothyronine (FT3), Free Thyroxine (FT4)), By Indication (Hypothyroidism, Hyperthyroidism, Thyroid Cancer, Other Indications), By End User (Clinics, Research Organizations, Diagnostic Laboratories, Hospitals) - Market Size, Trends, And Global Forecast 2026-2035
Thyroid Function Test Market Overview
• Thyroid Function Test market size has reached to $1.81 billion in 2025 • Expected to grow to $2.41 billion in 2030 at a compound annual growth rate (CAGR) of 5.7% • Growth Driver: Rising Incidences of Thyroid Disorders Fuel Growth In The Thyroid Function Test Market • Market Trend: Advanced RNA Sequencing Technologies Enhancing Precision And Accuracy In Thyroid Cancer Fusion Detection • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.What Is Covered Under Thyroid Function Test Market?
Thyroid function tests (TFTs) are a group of blood tests used to assess the function of the thyroid gland, which plays a crucial role in regulating metabolism and various bodily functions. These tests measure levels of thyroid hormones and other substances that influence thyroid activity to diagnose thyroid disorders and monitor their treatment. The main types of thyroid function tests are thyroid stimulating hormone (TSH), triiodothyronine (t3), thyroxine (t4), free triiodothyronine (ft3), free thyroxine (ft4). A thyroid-stimulating hormone (TSH) test measures the level of TSH in the blood, which is produced by the pituitary gland and stimulates the thyroid gland to produce thyroid hormones. The various indications include hypothyroidism, hyperthyroidism, thyroid cancer, and others that are used by various end users such as clinics, research organizations, diagnostic laboratories, and hospitals.
What Is The Thyroid Function Test Market Size and Share 2026?
The thyroid function test market size has grown strongly in recent years. It will grow from $1.81 billion in 2025 to $1.93 billion in 2026 at a compound annual growth rate (CAGR) of 6.5%. The growth in the historic period can be attributed to rising prevalence of thyroid disorders, increasing awareness of endocrine health, expansion of diagnostic laboratory networks, availability of standardized thyroid assays, routine inclusion of tsh testing in health checkups.What Is The Thyroid Function Test Market Growth Forecast?
The thyroid function test market size is expected to see strong growth in the next few years. It will grow to $2.41 billion in 2030 at a compound annual growth rate (CAGR) of 5.7%. The growth in the forecast period can be attributed to increasing adoption of personalized medicine approaches, rising demand for point-of-care thyroid testing, expansion of automated laboratory workflows, growing focus on early disease detection, increasing integration of digital diagnostics. Major trends in the forecast period include increasing adoption of high-sensitivity immunoassays, rising demand for early thyroid disorder screening, growing use of automated diagnostic platforms, expansion of comprehensive thyroid test panels, enhanced focus on diagnostic accuracy and standardization.Global Thyroid Function Test Market Segmentation
1) By Test Type: Thyroid Stimulating Hormone (TSH), Triiodothyronine (T3), Thyroxine (T4), Free Triiodothyronine (FT3), Free Thyroxine (FT4) 2) By Indication: Hypothyroidism, Hyperthyroidism, Thyroid Cancer, Other Indications 3) By End User: Clinics, Research Organizations, Diagnostic Laboratories, Hospitals Subsegments: 1) By Thyroid Stimulating Hormone (TSH): TSH Assay (Immunoassay, Electrochemiluminescence), TSH-Based Diagnostic Kits 2) By Triiodothyronine (T3): Total T3, Free T3, T3-Based Diagnostic Kits 3) By Thyroxine (T4): Total T4, Free T4, T4-Based Diagnostic Kits 4) By Free Triiodothyronine (FT3): FT3 Immunoassay, FT3 Electrochemiluminescence (ECL), FT3-Based Diagnostic Kits 5) By Free Thyroxine (FT4): FT4 Immunoassay, FT4 Electrochemiluminescence (ECL), FT4-Based Diagnostic KitsWhat Is The Driver Of The Thyroid Function Test Market?
The prevalence of thyroid disorder incidences is expected to propel the growth of the thyroid function test market going forward. Thyroid disorders are medical conditions that affect the function of the thyroid gland, a butterfly-shaped gland located in the front of the neck. Thyroid disorders are growing due to dietary changes, radiation exposure, hormonal changes, environmental factors, and autoimmune diseases. Thyroid function tests are vital for diagnosing and managing thyroid disorders by providing crucial information about thyroid hormone levels and antibody presence, guiding treatment decisions, monitoring therapy effectiveness, and preventing complications. For instance, in April 2024, according to the Journal of Global Health (JoGH), a UK-based non-profit organization, the number of thyroid cancer incidence cases is expected to reach approximately 305,078 by 2030. Therefore, the prevalence of thyroid disorder incidences drives the growth of the thyroid function test industry.Key Players In The Global Thyroid Function Test Market
Major companies operating in the thyroid function test market are F. Hoffmann-La Roche Ltd., Abbott Laboratories Inc., Thermo Fisher Scientific Inc., Danaher Corporation, Siemens Healthineers AG, Merck KGaA, BioMérieux Inc., WerfenLife SA, DiaSorin SpA, Beckman Coulter Life Sciences, Autobio Diagnostics Co. Ltd., Quidel Corporation, Boditech Med Inc., Cortez Diagnostics, Qualigen Inc., Ortho Clinical Diagnostics, Bio‑Rad Laboratories Inc., Sysmex Corporation, Randox Laboratories Ltd., Tosoh Corporation, FujirebioGlobal Thyroid Function Test Market Trends and Insights
Major companies operating in the thyroid function test market are developing innovative solutions such as RNA sequencing test to enhance the accuracy of cancer fusion detection across multiple solid tumors, including thyroid cancer. RNA sequencing (RNA-Seq) is a high-throughput technique that enables the analysis of the quantity and sequence of RNA in a sample, providing insights into gene expression and the overall transcriptome. For instance, in May 2024, Foundation Medicine, Inc. a US-based biotechnology company announced the U.S. launch of FoundationOne RNA, a tissue-based RNA sequencing test designed to detect cancer-related gene fusions across 318 genes. This test provides fusion reporting for all solid tumors and may be particularly useful in identifying fusions in cancers like non-small cell lung cancer (NSCLC), sarcoma, pancreatic cancer, thyroid cancer, cholangiocarcinoma, and bladder cancer.What Are Latest Mergers And Acquisitions In The Thyroid Function Test Market?
In January 2023, Thermo Fisher Scientific, a US-based biotechnology product development company, acquired The Binding Site Group for approximately $2.8 billion. With this acquisition is a strategic step for Thermo Fisher to broaden its diagnostic offerings, improve patient care, and capitalize on growth opportunities in the specialty diagnostics field. The Binding Site Group is a UK-based manufacturing company that specializes in the development and manufacture of immunodiagnostic products including tests for thyroid function.Regional Outlook
North America was the largest region in the thyroid function test market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.What Defines the Thyroid Function Test Market?
The thyroid function test market includes revenues earned by entities by providing thyroid antibody tests, total triiodothyronine test, total thyroxine test, and thyroglobulin tests. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.What Key Data and Analysis Are Included in the Thyroid Function Test Market Report 2026?
The thyroid function test market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the thyroid function test industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.Thyroid Function Test Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $1.93 billion |
| Revenue Forecast In 2035 | $2.41 billion |
| Growth Rate | CAGR of 6.5% from 2026 to 2035 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 - 2035 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2035 |
| Segments Covered | Test Type, Indication, End User |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, ... |
| Key Companies Profiled | F. Hoffmann-La Roche Ltd., Abbott Laboratories Inc., Thermo Fisher Scientific Inc., Danaher Corporation, Siemens Healthineers AG, Merck KGaA, BioMérieux Inc., WerfenLife SA, DiaSorin SpA, Beckman Coulter Life Sciences, Autobio Diagnostics Co. Ltd., Quidel Corporation, Boditech Med Inc., Cortez Diagnostics, Qualigen Inc., Ortho Clinical Diagnostics, Bio‑Rad Laboratories Inc., Sysmex Corporation, Randox Laboratories Ltd., Tosoh Corporation, Fujirebio |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |
